Table III.
Effect of Nexrutine intervention on inflammation, fibrosis in BK5-Cox-2 mice.
| Treatment | Animal ID# | Inflammation | Fibrosis | mPan 1A | mPan 1B | mPan 2 | mPan 3 |
|---|---|---|---|---|---|---|---|
| Control | PK12 100 | 0 | 0 | ||||
| Control | PK12 103 | 0 | 0 | ||||
| Control | PK12 104 | 0 | 0 | ||||
| Control | PK12 117 | 0 | 0 | ||||
| Control | PK12 125 | 0 | 0 | ||||
| Control | PK12 101 | 0.5+ | 0.5+ | ||||
| Control | PK12 102 | 0.5+ | 0.5+ | FOCAL | |||
| Control | PK12 116 | 0.5+ | 0.5+ | Y | |||
| Control | PK12 123 | 0.5+ | 0.5+ | ||||
| Control | PK12 124 | 0 | 0.5+ | ||||
| Control | PK12 126 | 0 | 0.5+ | ||||
| Control | PK12 127 | 0.5 | 0.5+ | ||||
| Control | PK12 128 | 0.5+ | 0.5+ | ||||
| Control | PK12 114 | 0 | 0.5A | ||||
| Control | PK12 62 | 1+ | 1+ | ||||
| Control | PK12 63 | 1+ | 1+ | ||||
| Control | PK12 64 | 1+ | 1+ | ||||
| Control | PK12 80 | 1+ | 1+ | ||||
| Control | PK12 115 | 0.5+ | 1+ | FOCAL | |||
| Control | PK12 66 | 2+ | 2+ | Y | |||
| Control | PK12 78 | 1+ | 2+ | Y | |||
| Control | PK12 91 | 0.5+ | 2+ | ||||
| Control | PK12 99 | 1+ | 2+ | Y | |||
| Nx | PK12 86 | 0 | 0 | ||||
| Nx | PK12 90 | 0 | 0 | ||||
| Nx | PK12 119 | 0 | 0 | ||||
| Nx | PK12 121 | 0 | 0 | ||||
| Nx | PK12 129 | 0 | 0 | ||||
| Nx | PK12 72 | 0.5+ | 0.5+ | ||||
| Nx | PK12 73 | 0.5+ | 0.5+ | ||||
| Nx | PK12 83 | 0 | 0.5+ | ||||
| Nx | PK12 84 | 0.5+ | 0.5+ | ||||
| Nx | PK12 88 | 0.5+ | 0.5+ | Y | |||
| Nx | PK12 89 | 0.5+ | 0.5+ | ||||
| Nx | PK12 118 | 0.5+ | 0.5+ | FOCAL | |||
| Nx | PK12 120 | 0 | 0.5+ | ||||
| Nx | PK12 122 | 0.5 | 0.5+ | ||||
| Nx | PK12 130 | 0.5+ | 0.5+ | ||||
| Nx | PK12 131 | 0 | 0.5+ | ||||
| Nx | PK12 74 | 1+ | 1+ | ||||
| Nx | PK12 77 | 1+ | 1+ | ||||
| Nx | PK12 85 | 0.5+ | 1+ | Y | |||
| Nx | PK12 87 | 1+ | 1+ | Y | |||
| Nx | PK12 133 | 1+ | 1+ | Y | |||
| Nx | PK12 79 | 1+ | 2+ | Y | |||
| Nx | PK12 132 | 3+ | 3+ | Y |